Medical Cannabis (MCC) - ICO rating and details

About Team Milestones Financial Ratings White paper

About Medical Cannabis

The Company offers Revenue Sharing to MCan’s coin Holders on a Monthly Basis.
The Company offers Dividend to MCan coin Holders on a quarterly basis.
The Company generously provides 1 free listed share for participants who hold 1000 MCan coins bought during Pre-ICO Period once the Company is listed on NASDAQ or London Stock Exchange.
Referral commissions of 5% will be distributed via smart contract to holders of Medical Cannabis (MCan) coins.
Pre-ICO Discount of 30% for MCan coins.
The Company firmly believes in Capital Appreciation of the MCan coins(ICO).
The Company strongly feels in the Positive Appreciation of the Listed Share (IPO).

Ratings

Benchy

ICO analyzer bot

2.8ICO Profile

100%weight

Experts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer's results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.

Ratings and ICO analyzer results are being updated (re-calculated) every few hours.

Press Releases

Blog

Team

Apply as an advisor

Chandra Sekar

Chairman

Avtar Chagger

CEO

Yossee Attias

CFO

Marta Mróz

Executive Director - Safety, Hygiene and Environment

Agnieszka Wieczorek

Blockchain Developer

Financial

Token info

Token

MCC

Platform

Ethereum

Type

ERC20

Price in ICO

0.1160 USD

Tokens for sale

2,750,000,000

Investment info

Min. investment

15 EUR

Accepting

ETH, BTC, XRP, Fiat

Distributed in ICO

50%

Milestones

2018

Project Conceptualization Started
Corporation with various blockchain specialist, advisors to form strategic alliance
Form Strategic Alliance with other Medical Cannabis Research and Cultivation companies
ICO - Pre-Sale & Institutional Sale
Pre- ICO 10% & ICO 50% of the coins will be distributed to expand EIMCR
Form strategic alliance with R&D departments in Universities in the area
Finalise discussions with Governmental figures

2019

Strategic Alliance with companies to produce MCan Products
Establishment of pharmaceutical manufacturing facilities
Production of MCan cultivation Begins
Adding more and the very best Consultants, Doctors and Scientists.
Medical Cannabis harvest
All Production of MCan Products Begins

2020

Aggressive expansion to 13 new countries
Expansion to new verticals, concrete plans set and teams ready to expand to 13 countries in 2 years.

2021

IPO (Initial Public Offering in major Global Exchanges)
NASDAQ, London Stock Exchange (LSE).
Further expansion & Global dominance
Aggressive marketing in current markets to 8 more new countries in 2 years.
Expansion of Manufacturing Facilities in few countries.
Blockchain era continues……

Medical Cannabis

Medical Revolution for Well-being of Humanity